Pacer Advisors
NARI

Pacer Advisors’s Inari Medical, Inc. Common Stock NARI Stock Holding History

Pacer Advisors’s Portfolio NARI Stock Details NARI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-7,622
Closed -$366K – 3798
2024
Q1 		$366K Sell
7,622
-66
-0.9% -$3.53K ﹤0.01% 1664
2023
Q4 		$499K Buy
7,688
+3,412
+80% +$205K ﹤0.01% 1514
2023
Q3 		$280K Sell
4,276
-9,595
-69% -$604K ﹤0.01% 1358
2023
Q2 		$806K Buy
13,871
+7,121
+105% +$449K ﹤0.01% 1236
2023
Q1 		$417K Sell
6,750
-2,496
-27% -$150K ﹤0.01% 1190
2022
Q4 		$588K Buy
9,246
+4,390
+90% +$318K ﹤0.01% 1142
2022
Q3 		$353K Buy
+4,856
New +$362K ﹤0.01% 1081

Other funds holding NARI

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
HM
HCC Manager Chicago, Illinois $10.3M AUM 6.8% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Brown Advisory
Brown Advisory Baltimore, Maryland $60.9B AUM 15.24% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
UBS AM
UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Pacer Advisors's NARI Position: Q2 2024 in Review

Pacer Advisors sold out of Inari Medical, Inc. Common Stock (NARI) in Q2 2024, closing a stake of 7,622 shares — an estimated $366K sold.

Pacer Advisors first reported a position in NARI in Q3 2022 and held it in 7 quarters. The position peaked at $806K in Q2 2023. 243 funds tracked by Wall St. Rank hold NARI as of Q2 2024.

  • Pacer Advisors reported no remaining Inari Medical, Inc. Common Stock position as of Q2 2024 after selling out during the quarter.
  • Pacer Advisors sold 7,622 Inari Medical, Inc. Common Stock shares in Q2 2024, an estimated $366K.
  • Pacer Advisors first reported a position in Inari Medical, Inc. Common Stock in Q3 2022 and held it in 7 quarters.
  • Pacer Advisors's Inari Medical, Inc. Common Stock position peaked at $806K in Q2 2023.
  • 243 funds tracked by Wall St. Rank held Inari Medical, Inc. Common Stock as of Q2 2024.

Based on Pacer Advisors's 13F filing for Q2 2024, filed 13 Aug 2024.